Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Neurology Devices by Type
5.1 Cerebrospinal Fluid Management Devices
5.1.1 Market Size and Forecast
5.2 Interventional Neurology Devices
5.2.1 Market Size and Forecast
5.3 Neurostimulation Devices
5.3.1 Market Size and Forecast
5.4 Neurosurgery Device
5.4.1 Market Size and Forecast
5.5 Others
5.5.1 Market Size and Forecast

Part 6. Global Market for Neurology Devices by Application
6.1 Ambulatory Surgery Centers
6.1.1 Market Size and Forecast
6.2 Hospitals
6.2.1 Market Size and Forecast
6.3 Neurology Clinics
6.3.1 Market Size and Forecast

Part 7. Global Market for Neurology Devices by Region
7.1 Asia-Pacific
7.1.1 Market Size and Forecast
7.2 Europe
7.2.1 Market Size and Forecast
7.3 North America
7.3.1 Market Size and Forecast
7.4 Middle East And Africa (Mea)
7.4.1 Market Size and Forecast
7.5 South America
7.5.1 Market Size and Forecast

Part 8. Key Competitor Profiles
8.1 Abbott Laboratories
8.2 B. Braun Melsungen AG
8.3 Boston Scientific Corporation
8.4 Integra LifeSciences Holdings Corporation
8.5 Johnson & Johnson
8.6 LivaNova, plc
8.7 Medtronic plc
8.8 Penumbra, Inc.
8.9 Stryker Corporation
*LIST IS NOT EXHAUSTIVE

Part 9. Patent Analysis
9.1 Patent Statistics
9.2 Regional Analysis
9.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY